Jin Medical International (ZJYL) Raw Materials (2022 - 2025)

Jin Medical International has disclosed Raw Materials across 4 years of filings, most recently posting $2.1 million for Q3 2025.

• Raw Materials for Q3 2025 came in at $2.1 million, up 1.76% year-over-year; the trailing twelve-month figure through Sep 2025 was $2.1 million (up 1.76% YoY), and the FY2025 annual result was $2.1 million, up 1.76% from the prior year.
• Raw Materials came in at $2.1 million for Q3 2025 at Jin Medical International, up from $2.1 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $3.3 million in Q3 2022 to a low of $2.1 million in Q3 2024.
• The 4-year median for Raw Materials is $2.4 million (2023), against an average of $2.5 million.
• Across the five-year window, Raw Materials fell 21.31% in 2024 and increased 1.76% in 2025, its largest moves.
• Jin Medical International's Raw Materials stood at $3.3 million in 2022, then decreased by 20.04% to $2.6 million in 2023, then dropped by 21.31% to $2.1 million in 2024, then grew by 1.76% to $2.1 million in 2025.
• The last three Raw Materials figures came in at $2.1 million (Q3 2025), $2.1 million (Q3 2024), and $2.6 million (Q3 2023), per Business Quant data.